Northborough, MA, United States of America

David Fournier

This inventor holds 28 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Molecular Detection Technology. Top assignees: Quanterix Corporation, Illumina Corporation, Ab Initio Technology LLC. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Fournier. Retrieved from https://idiyas.com/inventor/david-fournier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 96.4


 

Average Co-Inventor Count = 3.6

ph-index = 11

Forward Citations = 413(Granted Patents)


Location History:

  • Hudson, MA (US) (2008)
  • Hoboken, NJ (US) (2017 - 2019)
  • Northborough, MA (US) (2008 - 2024)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Molecular Detection
Raman Spectroscopy
Dynamic Range Extension
Biomolecule Assays
Optical Reader Systems
Data Processing
Confidential Information Detection
Optical Identification
Fluorescence Background
Capture Objects
Optical Scanners
Encoded Optical Substrates
28 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Fournier in Molecular Detection Technologies

Introduction: David Fournier, an accomplished inventor based in Northborough, MA, has made significant contributions to the field of molecular detection and analysis. With an impressive portfolio of 25 patents, Fournier has focused on enhancing the sensitivity and dynamic range of assays used to detect molecules or particles in fluid samples.

Latest Patents: Among his latest patents are groundbreaking innovations in ultra-sensitive detection methods. His work on the "Ultra-sensitive detection of molecules or particles using beads or other capture objects" presents systems and methods designed for detecting analyte molecules in fluid samples. This invention emphasizes the importance of immobilizing analyte molecules with capture objects to measure their concentration accurately. Additionally, his patent on "Methods and systems for extending dynamic range in assays for the detection of molecules or particles" describes techniques for spatially segregating analyte molecules to enhance assay effectiveness. By determining the percentage of locations containing analyte molecules, this method allows researchers to utilize both analog and digital detection systems for improved analysis.

Career Highlights: Throughout his career, David Fournier has worked with leading companies in the biotechnology sector, notably Quanterix Corporation and Illumina Corporation. His expertise in molecular detection has driven innovations that have far-reaching implications in medical diagnostics and research.

Collaborations: Fournier's work has been enriched through collaborations with notable coworkers, including David C. Duffy and David M. Rissin. By partnering with other skilled professionals, he has been able to advance his research and contribute to the development of novel technologies in his field.

Conclusion: David Fournier's inventive spirit and dedication to enhancing molecular detection technologies underscore his importance in the scientific community. With 25 patents to his name, his work not only exemplifies innovation but also paves the way for future advancements in molecular analysis, potentially transforming the landscape of research and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…